Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FAPI PET/CT in various cancers
NCT05810324Unknown
- Sponsor
- Jilin University
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of [18F]AlF-NOTA-FAPI-04 in cancer, sponsored by Jilin University. Primary endpoint: Diagnostic accuracy at 1 year. Status: unknown.
02
Drugs
[18F]AlF-NOTA-FAPI-04
03
Conditions
cancer
Beyond the preview
Go deeper on NCT05810324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05810324.